More about

Psoriasis

News
August 22, 2024
11 min listen
Save

Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of August 19, 2024

Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of August 19, 2024

In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more.

News
August 20, 2024
2 min read
Save

Cal/BDP cream preferred over foam formulation among patients with psoriasis

Cal/BDP cream preferred over foam formulation among patients with psoriasis

Calcipotriol/betamethasone dipropionate, or CAL/BDP, combination cream vs. foam had higher satisfaction ratings among patients with psoriasis, suggesting the cream formulation may increase adherence, according to a study.

News
August 17, 2024
1 min read
Save

Catch up with top psoriasis news for Psoriasis Action Month

Catch up with top psoriasis news for Psoriasis Action Month

The National Psoriasis Foundation dedicated August to psoriasis education, awareness and education, designating it Psoriasis Action Month.

News
August 16, 2024
7 min read
Save

‘Pristine’ safety profile sets TYK2i apart from JAK ‘baggage’ in psoriatic disease, lupus

‘Pristine’ safety profile sets TYK2i apart from JAK ‘baggage’ in psoriatic disease, lupus

In September 2022, the FDA approved deucravacitinib for moderate-to-severe plaque psoriasis, officially introducing tyrosine kinase 2 inhibition to clinics across the United States.

News
August 15, 2024
2 min read
Save

Guselkumab de-escalation maintains psoriasis control in patients with early skin clearance

Guselkumab de-escalation maintains psoriasis control in patients with early skin clearance

In patients with early and complete clearance of psoriasis, extending the guselkumab dosing interval to every 16 weeks maintained disease control as well as an 8-week interval, according to a study published in JAMA Dermatology.

News
August 13, 2024
2 min read
Save

Patients, clinicians support use of as-needed biologic therapy for psoriasis

Patients, clinicians support use of as-needed biologic therapy for psoriasis

Patients and clinicians agree that as-needed use of biologic therapy has benefits over continuous long-term biologic use for the treatment of psoriasis, according to a study.

Clinical Guidance
Psoriatic Arthritis
Primary Care Guide

Primary Care Physician Guide to Psoriatic Disease

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Psoriatic Arthritis
Treatment Options

Other Biologic Therapy for PsA

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Psoriatic Arthritis
Coordinated Management

Coordinated Management

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Psoriatic Arthritis
Treatment Options

TNF Inhibitor Therapy for Psoriatic Arthritis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

View more